-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Fusion Pharmaceuticals Inc. quarterly/annual Revenues history and growth rate from Q2 2021 to Q4 2023.
- Fusion Pharmaceuticals Inc. Revenues for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
- Fusion Pharmaceuticals Inc. Revenues for the twelve months ending December 31, 2023 was $2.07M, a 41.5% increase year-over-year.
- Fusion Pharmaceuticals Inc. annual Revenues for 2023 was $2.07M, a 41.5% increase from 2022.
- Fusion Pharmaceuticals Inc. annual Revenues for 2022 was $1.46M, a 1.46% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)